Samuel Ogunsalu

Senior Advisor Corporate Strategy & Business Development at Temple Therapeutics

Samuel Ogunsalu is a seasoned professional with a strong academic background and extensive experience in the fields of business, technology, and commercial development.

He holds a Bachelor of Science (BS) degree from Aberystwyth University and a Master of Engineering (MEng) degree from University College London (UCL).

Throughout his career, Samuel has held various significant positions, including Partner at Lancea LLP, Senior Advisor at Lancea LLP, Chief Business Officer at a Biotech consulting firm, Chief Commercial Officer at a Biotech consulting firm, Technology Consultant at Stargate Capital, Head of Commercialisation at Knowledge East, Commerialisation Consultant at St Petersburg Commercialisation Project, and Principal Executive of Commercial Development at Queen Mary, University of London.

Experience

Senior Advisor Corporate Strategy & Business Development at Temple Therapeutics (January 2020 - Present)

Partner at Lancea LLP (October 2016 - Present), Various roles including Senior Advisor at Lancea LLP, Chief Business Officer, Chief Commercial Officer, Principal Executive at Queen Mary University of London, Head of Commercialisation at Knowledge East